Form D · Biotechnology
Gruene Anolyte, LLC
Fort Worth, TX · CIK 0001783738
Offering snapshot reported Jul 30, 2019 · SEC filing
- Reported sold
- $100K Offering amount: $4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 18, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2019 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345333
Convertible Promissory Notes convertible into equity securities of the Issuer.
Source: Form D, filed Jul 30, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas C. Binzer | Director |
| Stephen D. Newman | Director |
| Mary Palko | Director |
| Clinton Weber | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4309 Cumberland Rd. North
Fort Worth, TX, 76116
Fort Worth, TX, 76116